{"version":"1.0","type":"link","title":"Dynamic liver dysfunction predicts poor survival in patients with EGFR-mutant non-small cell lung cancer and liver metastases treated with EGFR tyrosine kinase inhibitors.","author_name":"Zhang W 외","author_url":"https://prs-insight.online/author/Zhang%20W","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/98361","thumbnail_width":1200,"thumbnail_height":630}